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Abstract
It has been shown that stem cells are able to calcify both in vitro and in vivo once implanted under the skin, if
conveniently differentiated. Nowadays, however, a study on their efﬁciency in osseous regeneration does not exist in
scientiﬁc literature and this very task is the real aim of the present experimentation. Five different defects of 6 mm in
diameter and 2 mm in depth were created in the calvaria of 8 white New Zealand rabbits. Four defects were
regenerated using 2 different conveniently modiﬁed scaffolds (Bio-Oss® Block and Bio-Oss Collagen®, Geistlich),
with and without the aid of stem cells. After the insertion, the part was covered with a collagen membrane ﬁxed by 5
modiﬁed titan pins (Altapin®). The defect in the front was left empty on purpose as an internal control to each animal.
Two animals were sacriﬁced respectively after 2, 4, 6, 10 weeks. The samples were evaluated with micro-CT and
histological analysis. Micro-CTanalysis revealed that the quantity of new bone for samples with Bio-Oss® Block and
stem cells was higher than for samples with Bio-Oss® Block alone. Histological analysis showed that regeneration
occurred in an optimal way in every sample treated with scaffolds. The ﬁndings indicated that the use of adult stem
cells combined with scaffolds accelerated some steps in normal osseous regeneration.
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Introduction
The repair of bone defects continues to be a
challenging part of many reconstructive procedures[1–2].
Although autogenous bone grafts remain the standard in
the reconstruction of bone defects, they have disadvan-
tages, including the limited amount of available bone
and morbidity of the donor site[3].
A previous approach to this problem focused on the
development of various artiﬁcial materials instead of
autogenous bone. However, artiﬁcial bone substitutes
may expose the patient to the risks of foreign body
reactions and infections[4].
Recent advances in cell culture techniques may
provide an elegant solution to these restrictions[5].
Several recent studies have reported the ubiquitous
distribution of adult stem cells in various tissues and
organs, including bone marrow, muscle, brain, skin, and
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more recently, subcutaneous fat. Stem cells represent
the new frontier in the ﬁeld of regenerative medicine
and are seen as a promising and suitable means to
overcome the mentioned drawbacks[6].
Several studies report that adult stem cells can be
isolated from many organs and tissues[2]. In particular,
adipose tissue contains cells that have the ability to
proliferate and differentiate into multiple cell lines[1,7].
These stem cells may have important applications in
tissue engineering. As a matter of fact, adipose tissue-
derived stem cells (ADSCs) have the potential to
differentiate into bone, cartilage, fat, myocardium, skin,
and neurons[8–9]. In current clinical practice, mesench-
ymal stem cells are commonly collected from the bone
marrow. However, no signiﬁcant differences between
adipose-derived stem cells and bone marrow-derived
mesenchymal stem cells from the same patient were
observed with regard to the yield of adherent cells, their
growth kinetics, cell senescence, differentiation capa-
city, and gene transduction efﬁciency[10–11]. Moreover,
adipose tissue can be collected under local anesthesia
more easily than bone marrow, making the procedure
less invasive to the donor[12–13].
The aim of this study was to investigate the
differences in vivo between traditional bone regenera-
tion and the combination with tissue engineering in the
animal model.
Materials and methods
Eight New Zealand rabbits weighing about 4.5 kg,
treated according to the "European conventions for the
protection of vertebrate animals used for experimental
and other scientiﬁc purposes" (1999/575/EC) and
Italian regulations (DL 116.1993), underwent the ﬁrst
surgery for the removal of adipose tissue. The animals
were operated under anesthesia with Xylazine and
Zoletil ®. After shaving and disinfecting the skin with
Betadine ®, a ﬂap was created for the removal of
intrascapular adipose tissue. A single withdrawal in
each animal was made from their adipose tissue and
stem cells were subsequently isolated to avoid problems
of rejection and the inconvenience of intervening in
immunosuppressed animals. In this way any replanting
will be possible with self cells taken directly from the
animal. After collection, Vicryl ® sutures and an
additional Betadine ® disinfection on the skin were
performed. In the following days, the animals were
given an antibiotic and anti-inﬂammatory analgesic
therapy with enroﬂoxacin (Baytril ®) and carprofen
(Rimadyl ®) to prevent complications.
Isolation of adult mesenchymal stem cells
The removed adipose tissue was transported in the
laboratories of SISSA of Trieste, where the process of
isolation of mesenchymal stem cells immediately
began. The extracellular matrix was digested by a
0.1% collagenase solution in a water bath at 37 °C for
60 minutes. Thereafter, the cells obtained were seeded
in Dulbecco's modiﬁed Eagle's medium containing 10%
bovine serum and antibiotics (control medium) and
centrifuged for 3 minutes at 1,500 r/minute. Then, yjey
were ﬁltered through a nylon membrane with a pore size
of 100 µm and the cells were placed in control medium
culture. The selection of cells that adhered to diskette
and the gradual elimination of adipocytes were made
following a well described protocol by Rietze et al.[14].
Preparation of scaffolds
To support cell growth in the plant site we decided to
use two different scaffolds produced by Geitslich ®:
deproteinized bovine bone (Bio-Oss ® Block Geistlich)
and bovine cancellous granular with the addition of a
collagen matrix to 10% (Bio-Oss Collagen ® Gei-
stlich). The Bio-Oss ® Block was processed under
sterile conditions to obtain discs with a diameter of
5 mm and a thickness of 2 mm so that it ﬁts perfectly
with the type of defect.
The Bio-Oss Collagen ® were cut in two portions,
since preliminary experiments suggested that this was
the amount needed to adequately ﬁll the defect.
Osteogenic differentiation
For osteogenic differentiation, it was decided to adopt
a protocol developed by Kakudo, which was already
well documented. Cells differentiated in this way are
able to calcify very quickly if implanted subcuta-
neously, but there is no evidence in the literature on the
present operation to repair a critical defect. A total of
1,000,000 cells were seeded in each scaffold in control
medium and kept for 24 hours. Thereafter, the medium
was replaced with osteogenic medium, obtained by
adding to the control medium 10 nmol/L dexametha-
sone, 10 mmol/L of β-glycerophosphate 82 g/mL
acorbato-2 phosphate, and cells were allowed for
differentiation for 14 days. The osteogenic medium
was replaced 2 times every 7 days for a total of four
substitutions.
Creating experimental bone defect and plant
The second surgery mode of sedation and anesthesia
were the same as the ﬁrst. The ﬂap was prepared for
skeletonization of the parietal bones of the calvaria of
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rabbits. We proceeded to create ﬁve experimental bone
defects (two on each parietal bone and one before that)
of 6 mm in diameter and 2 mm in depth. Defects can be
produced with standardized trephine burs, using con-
tinuous saline irrigation for cooling[15]. Using a special
caliber created for the experiment, we checked the
precise size of defects before insertion of the scaffolds
alone and enriched with cells differentiated into the
osteogenic line.
Defects were grafted differently: on the right of the
rabbit head, with Bio-Oss ® Block and mesenchymal
stem cells in the caudal defect and with Bio-Oss
Collagen ® and mesenchymal stem cells in the cranial
one; on the left, Bio-Oss ® Block in the caudal defect
and Bio-Oss Collagen ® in the cranial one, both without
the addition of stem cells. The ﬁfth defect, the frontal
one, was left empty and used as internal control in each
animal (Supplementary Fig.1, available online). The
defects ﬁlled with different materials were coated with a
collagen membrane (BioGide Geistlich ®) ﬁxed with 5
specially modiﬁed titanium pins (Altapin ®).
Finally, the ﬂaps were sutured by wire Vicryl ® 3/0
and steel clips were applied outside on the skin,
preventing the reopening of the ﬂap. The skin was
disinfected again with Betadine ® and animals were
treated with antibiotic (enroﬂoxacin, Baytril ®), and
anti-inﬂammatory/analgesic (car-profen, Rimadyl ®)
therapy. No animal showed signs of suffering during the
postoperative period, tightly controlled and recorded in
audiovisual behavior. Thanks to the developed surgical
technique, it was not necessary to complete any sacriﬁce
before the scheduled date.
Sacriﬁce and sampling
Two animals were sacriﬁced by intravenous injection
of Tanax ® after general anesthesia with Zoletil ®
respectively at 2, 4, 6 and 10 weeks. The bone samples,
taken immediately after sacriﬁce, were immersed in 4%
buffered formaldehyde. Every sample was subjected to
Micro-CT scan and then to histological analysis.
Preparation of samples
The marked samples were immersed in a solution of
40% formic acid and formate buffer in a 1:1 ratio for
5 days, long enough to ensure adequate decalciﬁcation.
Samples were then post-ﬁxed overnight in 10%
buffered formalin, dehydrated through an ascending
scale of alcohols (from 50% to 100%), clariﬁed with
xylene and ﬁxed with permeating liquid parafﬁn at
60 °C. The material was then embedded in parafﬁn
solidiﬁed at room temperature, so it was possible to
obtain histological sections 5–10 µm thick, spread on
glass slide. The sections were stained with hematoxylin
to highlight nucleus and eosin for intra- and extra-
cellular structures.
Micro-CT data analysis
X-ray microcomputed tomography (µ-CT) of sam-
ples was obtained by means of a cone-beam system
called TOMOLAB (www.elettra.trieste.it/Labs/TOMO-
LAB). The device is equipped with a sealed microfocus
X-ray tube, which guaranteed a focal spot size of 5 µm
in an energy range from 40 up to 130 kV, and a
maximum current of 300 µA. As a detector, a CCD
digital camera was used with a 49.9 mm33.2 mm ﬁeld
of view and a pixel size of 12.5 µm12.5 µm. The
samples were positioned onto the turn-table of the
instrument and acquisitions were performed with the
following parameters: distance source-sample (FOD)
100 mm; distance source-detector (FDD) 200 mm;
magniﬁcation 2; binning 22; resolution 12.5 µm;
tomographies dimensions (pixels) 1,9841,024; slices
dimensions (pixels) 1,9841,984; number of tomogra-
phies 1,440; number of slices 864; E = 40 kV, I = 200
µA; exposure time 2.5 seconds. The slices reconstruc-
tion process achieved by means of commercial software
(Cobra Exxim) started once the tomographic scan was
completed and all the projections were transferred to the
workstation. Input projections and output slices were
represented by ﬁles (one ﬁle per projection and one ﬁle
per slice) using arrays of 16-bit integers. Three-
dimensional visualizations of the reconstructed slices
were performed by means of OsiriX v.3.9.4. 64bit
Imaging Software. This software allowed identiﬁcation
of the correct angulation and segmentation of the
samples from which the planar view was extracted.
From the planar view, the percentage of newly formed
bone was calculated as the rate between the volume of
the newly formed bone on the volume of the original
defect. Calculation was performed by means of Image
ProPlus 6.2 software. The image analysis procedure was
assisted by a surgeon, expert of radiographies, to
identify the orientation and the correct border between
the newly formed bone and the native bone (Supple-
mentary Fig. 2, available online). Through the use of a
code written in IDL, we cored three volumes of
12812836 voxels (the ﬁrst on the original bone
structure adjacent to the defect, the second on the
scaffold and the third at the interface between the two),
binarized by Otsu algorithm for evaluation of class
separability threshold[16] implemented in software
PORE3D.
Later, through the program GEHC MicroView,
selected volumes of interest were analyzed by the
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stereological parameters, using Euler number (e) as a
selected parameter. e is a direct index of trabecular
connectivity and can be deﬁned as the maximum
number of portions removable from the structure
without losing its integrity. e was normalized for the
parameter BVTV (bone volume/total volume)[17–19]
Histological analysis
Immediately after µ-CT scans, the samples were sent
to the Department of Pathology of the Hospital of
Monfalcone (Gorizia, Italy) to perform histological
analysis. Samples were immersed in a solution of EDTA
(ethylenediaminetetraacetic acid) disodium in acid
buffer for ﬁve hours. Samples were then placed in
histology cassettes properly oriented. The biocassettes
were then included in the histoprocessor where, with a
predetermined sequence and timing, the samples were
post-ﬁxed in 10% buffered neutral formalin, dehydrated
through an ascending scale of ethanol (from 50% to
100%), clariﬁed with xylene and permeated by liquid
parafﬁn at 60 °C. The material was then embedded in
parafﬁn and allowed to solidify on chilled plates. The
obtained block was then sectioned by a microtome and
8 µm thick histological sections were spread on a glass
slide and placed in an oven at 60 °C for 1 hour to ensure
a good adhesion of the sections to the glass slides and at
the same time to dissolve the parafﬁn excess. Subse-
quently, the sections were stained with hematoxylin and
eosin. After the staining, the preparations were
dehydrated and mounted with resin, which was placed
on the coverslip. During histological analysis of the
samples, we focused on the following fundamental
aspects:
- Comparison between the ossiﬁcation with and
without matching mesenchymal stem cells to two
different scaffolds;
- Comparison of the integration of the scaffolds in the
context of the newly formed tissue, with and without
using mesenchymal stem cells.
Results
Micro-CT data results
Similar ﬁndings were registered in all the analyzed
samples: the quantity of new bone (higher gray levels)
showed a trend to increase with the animals’ age. When
comparing the graphic curves obtained for both Bio-Oss
® and Bio-Oss ® with mesenchymal stem cells, the
quantity of new bone for the Bio-Oss ® with
mesenchymal stem cells samples was higher when age
was considered. In particular, the 10-week samples with
stem cells presented a more differentiated gray level
than the 10-week samples without stem cells (Fig. 1).
Histological analysis results
Specimens at 2 weeks: There were no inﬂammatory
cells around the particles in animals treated with
deproteinized bovine bone material associated with
mesenchymal stem cells. Most particles were sur-
rounded by newly formed connective tissue. In some
areas, newly formed bone matrix was ﬁrmly adhering to
the surface of the deproteinized bovine bone, with no
spaces at the interface. In other areas, the islands of
newly formed connective tissue were not closely related
to the particles of deproteinized bovine bone material. In
these cases, the surface was almost entirely covered by
rounded cells that appeared to be active and wrinkled by
a dense extracellular matrix. The ﬁndings of the left side
defects were characterized by the presence of ﬁller
material with connective tissue around it. Deproteinized
bovine bone units were easily distinguishable from
newly formed connective tissue in the samples (Fig. 2).
Specimens at 4 weeks: The histological study of the
side shows areas of connective tissue with clearly
distinguishable areas of newly formed bone tissue. In
particular, bone tissue presented a typical structure of
bone tissue such as lamellar histological structure (Fig.
3). Moreover, scaffold particles were still distinguish-
able from newly formed bone tissue and connective
tissue. There was no inﬂammatory inﬁltrate at the
Fig. 1 Comparison of pixel frequency of gray level in the
samples treated with Bio-Oss without stem cells (A) or Bio-Oss
and stem cells (B) at different weeks.
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interface or around the particles. In the control side,
histology was consistent with that shown at 4 weeks
(Fig. 4).
Specimens at 6 weeks: In the test side, particles of
scaffold surrounded by maturing bone were easily
visible (Fig. 5 and 6).
Specimens at 10 weeks: In samples of last sacriﬁced
animals complete ossiﬁcation, demonstrated by trabe-
cular bone structure still maturing, absence of con-
nective tissue, completely replaced by bone in every
regenerated defects. Only in the empty defect we can
observe trabecular bone still surrounded by islands of
connective tissue.
As a very important result, histology conﬁrmed the
formation of the ossiﬁcation front already deducible
from micro-CT analysis. This ossiﬁcation front was a
zone of lower density of both healthy bone and scaffold,
situated at the interface and growing with the temporal
distance between the implant and animal sacriﬁce (Fig.
6 and 7).
There seems to be no signiﬁcant differences in
regeneration between Bio-Oss ® Block and Bio-Oss
Collagen®. Both scaffolds were not easy to handle:
Bio-Oss ® Block must be specially modiﬁed in order to
adapt to the defect. Its solid structure was optimal to
support the overlying tissues and to provide the needed
support for the bone to regenerate. On the contrary, Bio-
Oss Collagen® instead had a spongiform structure
losing most of its mechanical ability in contact with the
blood. It was also not indicated for supporting tissues.
Nevertheless, it is extremely easy to handle by non
expert operators and it is an excellent medium for
growing the bone.
Discussion
Eight New Zealand rabbits were used for this study.
Fig. 2 Haematoxylin-eosin staining, at two-week sample. A:
Bio-Oss® Block without stem cells (100); B: Bio-Oss® Block with
stem cells). Note the bone tissue (b) and connective tissue (c) (200).
Fig. 3 Newly bone tissue. The Haversian canal is located in the
center of the image (100).
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After surgery and up to the date of sacriﬁce, the
recovery of all the animals involved in this study was
considered normal in terms of eating behavior, weight
and quality of life. To the best of our knowledge, in the
present literature, there is no evidence of a general
agreement on the correct animal model to be used for
scientiﬁc purposes similar to the ones involved in this
study. Some authors claim that one should use a model
in which bone biology and composition is very similar
to that of humans (i.e. dog, sheep, goat, pig or
monkey)[20]. Indeed, they claim that the trabecular
bone contained in rodent bones is poor also in the
metaphysis of long bones and that re-modeling of
Haversians channels by osteoclastic re-absorption does
not happen in rodents[21]. On the contrary, other authors,
without denying the previous observations, claim that
the use of the above mentioned animal models present
some drawbacks[2]. Rodents are the most common
animals employed during in vivo studies reported in the
literature; this is mainly related to practical reasons:
large animals are more expensive, time consuming and
more difﬁcult to keep.
There are multiple factors that affect osseous bone
healing that are best evaluated in the in vivo environ-
ment, including biomechanical, cellular and vascular
mechanics that comprise the healing process. The model
chosen to assess a particular device should mimic the
environment in which the device will be used
therapeutically. One should choose a “critical-size
defect” that will not spontaneously regenerate, to best
characterize the contribution of the device to healing.
Tissue engineering devices can be screened in various
preclinical animal models to determine their potential.
Depending on previous data on a product, one can
choose the appropriate model to screen the potential of a
new device. For new technology, it is advised to begin
with small animal models, which can provide early data
in a relatively fast and cost-effective way. This kind of
research can progress with systems that simulate the
human wound and therapeutic environment more
closely in association with the planned clinical applica-
tion of the device[22].
Both scaffolds exhibit open-pore structures allowing
cell penetration and attachment[23–25]. Numerous stu-
dies have employed defects in the calvarium as the site
in which to screen biomaterials for the bone response
that they elicit, principally because the diameter of the
Fig. 5 Hematoxylin-eosin staining, showing the Bio-Oss®
Block without stem cells at 6 weeks (100).
Fig. 6 At 6 weeks Bio-Oss® Block (a) with stem cells and bone
tissue (b) (100).
Fig. 4 At 4 weeks Bio-Oss Collagen ® with stem cells (100).
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critical-size defect is smaller than that in long bone sites.
Another advantage is that multiple defects can be
produced in the same surgical ﬁeld. An incision is made
through the scalp to expose the periosteum, which is
then elevated and retracted to expose the bone. Defects
can be produced with standardized trephine burs, using
continuous saline irrigation for cooling. The biomaterial
can then be placed into the defects[26].
Having shown no difference between two scaffold-
groups regarding bone regeneration, micro-CT and
histological examination revealed the presence of early
bone changes.
Modern techniques of bone regeneration are still very
far from satisfactorily resolving all situations in which
they are needed. Considerable help in the future could
come from Tissue Engineering. This last can provide
new and "targeted" tools enabling tissue-regenerating
stimuli to arrive at the aimed cellular lines only. The
new bone, formed with adipose derived stem cells,
seems to be superposable with that obtained by
traditional regenerative technique, both in the histolo-
gical appearance and in the timing of neodeposition and
calciﬁcation of the extracellular matrix. Further studies
should be conducted in order to understand what the
contribution is to regeneration of adult stem cells. The
engineering of biomaterials plays a major role in this
ﬁeld. Indeed, the use of selected and differentiated cells
should be combined with a specially designed scaffold,
allowing amplifying the cells potential. Currently, there
is no available scaffold meeting all the requirements of
tissue engineering and research should be focused in
this direction.
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